Cancer Genetics Inc. (CGIX) Rose 7.79% or 0.02 To Price $0.22 On Wednesday


Cancer Genetics Inc. (CGIX) rose 7.79% or 0.02 to $0.22. It is near 89014 shares traded, which is 46.06% compare to the average total volume 193267. The market cap of CGIX is $6.10 million. The year to date change is -81.74%. The 52 week price range is from $0.2 to $2.25. Price of CGIX have changed -12.45% during last week. It have changed -64.09% over last month, -79.18% over last 3 months, -80.93% over last 6 months and -88.97% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CGIX is 0.64. It is 190.91% above current price. The 200-day Moving Averages for CGIX is 1.01. It is 359.09% above current price. The 52-week High is 2.25. It is 922.73% from the current price. The 52-week Low is 0.2. It is -9.09% from current price.

There are some statistics of CGIX. It is has market cap $6.10 million. The share outstanding is 27.75 million. The average volume is 193267. The percent of top 15 Institution holding is 14.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CGIX is -122.34%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CGIX is -52.54%.


Tags:

Share this post